Bioxytran Inc
(BIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 114 | 112 | 266 | 545 | 850 |
| Operating Income | -114 | -112 | -266 | -545 | -850 |
| Interest Expense | 87 | 740 | 108 | 15 | 10 |
| Other Income | -1 | -76 | -167 | -103 | -14 |
| Pre-tax Income | -202 | -929 | -541 | -663 | -874 |
| Net Income Continuous | -202 | -929 | -541 | -663 | -874 |
| Net Income | $-202 | $-929 | $-541 | $-663 | $-874 |
| EPS Basic Total Ops | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Total Ops | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| EBITDA(a) | $-98 | $-36 | $-99 | $-397 | $-882 |